ReviewFrontiers in nutrition2025
Nutrient metabolism and complications of type 2 diabetes mellitus: implications for rehabilitation and precision care.
Review in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- CRISPR Technologies in Type 2 Diabetes: From Mechanistic Insights to Therapeutic Discovery.International journal of molecular sciences · 2026Review
- HALP score and risk of renal progression in diabetic kidney disease.Acta diabetologica · 2026Article
- Chitosan-Based Nanocarriers Co-Delivering Pioglitazone and Curcumin: Biological Activity and Therapeutic Potential in Diabetes.International journal of molecular sciences · 2026Article
- Article
- Precision nutrition in diabetic foot ulcers: multimodal artificial intelligence for personalized metabolic management.Frontiers in nutrition · 2026Review
- Nutrigenomics meets multi-omics: integrating genetic, metabolic, and microbiome data for personalized nutrition strategies.Genes & nutrition · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Systemic disruptions in the metabolism of carbohydrates, fats, proteins, and micronutrients cause micro- and macro-vascular damage and impede recovery, which is the driving force behind type 2 diabetes mellitus (T2DM). Neuropathy, nephropathy, foot ulcers, and sarcopenia are symptoms of persistent hyperglycemia, lipotoxicity, excess branched-chain amino acids, and deficiencies in magnesium, zinc, and vitamin D that impair insulin signaling, mitochondrial integrity, and tissue repair. Functional decline is accelerated in skeletal muscle and peripheral nerves due to advanced glycation end-product deposition, ectopic lipid accumulation, and impaired glucose uptake. Micronutrient deficiency hinders wound healing and immune function, while altered nitrogen handling and progressive albuminuria intensify catabolism in the kidney. Controlled protein intake, micronutrient replacement, and microbiome-informed precision diets are targeted nutritional interventions that reduce complications by preserving renal function, restoring nerve integrity, and promoting wound closure. By combining machine learning analytics with continuous glucose monitoring, macronutrient ratios can be changed in real time, improving individualized care. Improved mobility, less neuropathic pain, and better glycaemic control are the results of integrating systematic nutritional assessment and treatment into multidisciplinary rehabilitation protocols. The translation in standard practice continues to be obstructed by inconsistent evaluation tools, lack of availability of omics technologies and few nurse-led randomized trials. Future studies must comprehensively evaluate the long-term effectiveness, cost-effectiveness, and scalability of tailored nutrition in rehabilitation frameworks to lessen the burden of complications and restore functional autonomy in people suffering from type-2 diabetes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.